FDA Warns Nine Companies for Distributing Unapproved Drugs

The FDA has sent warning letters to nine distributors of unapproved drugs — at least three of which purchased the products from ANIP Acquisition, which received a warning letter earlier this year for selling unapproved pharmaceuticals. The agency sent the similarly worded warning letters to companies distributing unapproved, misbranded and adulterated drugs, which were dated Nov. 13 and posted recently on the FDA website.
Washington Drug Letter